Trial intelligence / Profile preview

Capsaicin infusion effects on esophageal mucosal integrity in healthy volunteers

NL-OMON42198Active, not recruiting

Sponsor
Maastricht University Medical Center+
Start
Nov 2015
Modality
Small Molecules
Countries
1
01

Overview

Open-label trial of capsaicin (2 arms), sponsored by Maastricht University Medical Center+. Primary endpoint: Baseline impedance after capsaicin versus control infusion. Started Nov 2015; status: active, not recruiting.

02

Drugs

capsaicin

Beyond the preview

Go deeper on NL-OMON42198.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON42198.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call